In Win For Barr, Court Denies Tamoxifen Rehearing
Law360 (September 18, 2006, 12:00 AM EDT) -- Marking a victory for Barr Pharmaceuticals Inc. in a long-running case over authorized generics, the U.S. Court of Appeals for the Second Circuit has denied a bid for rehearing by a...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
